|
Balance Sheet Cash Flow Statement 6166 Nancy Ridge Dr. San Diego, CA 92121 CA Tel. 858-453-7200 Fax 858-453-7210 |
Type: Public
On the web:
http://www.arenapharm.com
Employees:
499
Employee growth: 1.6%
Though not a football team, Arena Pharmaceuticals likes the end-around. The firm's CART technology discovers drugs without first identifying ligands, the molecules that bind to a drug's potential target and trigger a biological response. The technology mimics the behavior of ligands to identify chemical compounds that alter biological responses, facilitating faster drug discovery. Arena's focus is on treatments for metabolic, cardiovascular, and central nervous system diseases. Lead drug candidate lorcaserin could help obese people control body fat. Arena earns most of its revenues from R&D partnerships, including one with Ortho-McNeil Pharmaceutical to develop a treatment for type 2 diabetes.
Key numbers for fiscal year ending December, 2008:
Sales: $9.8M
One year growth: (49.3%)
Net income: ($237.6)M
Officers:
Chairman, President, and CEO: Jack (Jackie) Lief
VP Finance and CFO: Robert E. Hoffman
Senior Communications Associate: Cindy McGee
Competitors:
Abbott Labs
Hoffmann-La Roche
Sanofi-Aventis
